Explain Pityriasis rosae with treatment and images

Reading File

Finding Sources

Searching the Web

pityriasis rosea clinical features treatment 2024

Searching Images

pityriasis rosea herald patch skin rash

Reading File

Searching PubMed

pityriasis rosea treatment acyclovir

Reading File

Loading Image

I now have comprehensive textbook content and images. Let me compile the full answer.

Pityriasis Rosea

Overview

Pityriasis rosea (PR) is a mild, self-limiting inflammatory exanthem of likely viral origin. It affects all ethnic groups, most commonly between ages 15–40 years, with a slight female predominance. Incidence is 3–30 per 1,000 patients, with peak occurrence in spring and autumn. — Andrews' Diseases of the Skin; Goldman-Cecil Medicine

Etiology & Pathogenesis

PR is most likely a response to a viral infection. The strongest evidence implicates Human Herpesvirus 6 (HHV-6) and HHV-7 — both herpesviruses almost universally acquired in early childhood that remain latent in mononuclear cells. The eruption is believed to result from reactivation leading to viremia. Active replication of HHV-6 or HHV-7 has been demonstrated in mononuclear cells of lesional skin, with the viruses also identified in serum.

HHV-2 and hepatitis C virus (HCV) have also been implicated in individual cases. — Andrews' Diseases of the Skin

Drug-induced PR-like eruptions can be caused by: captopril, lisinopril, imatinib mesylate, interferon, ketotifen, arsenicals, gold, bismuth, clonidine, barbiturates, adalimumab, lamotrigine, rituximab, and BCG vaccine, among others.

Clinical Features

Phase 1 — The Herald (Mother) Patch

In 50–90% of patients, the eruption begins with a single herald patch: a salmon-pink to erythematous, oval or circinate, scaly patch 2–5 cm in diameter. It is often solitary for 1–2 weeks before the generalized eruption appears and is frequently mistaken for tinea corporis because of its annular appearance with central collarette of scale.

Herald patch — oval erythematous plaque with peripheral collarette scale (Andrews' Fig. 11.2)

Herald patch — well-defined oval plaque with collarette scaling (Andrews' Diseases of the Skin, Fig. 11.2)

Phase 2 — Generalized Eruption

After the herald patch, smaller salmon-colored oval plaques and papules erupt rapidly, predominantly on the trunk and proximal extremities, sparing sun-exposed surfaces (face, hands, feet). Key features:

"Christmas tree" or "fir-tree" distribution — lesions align along Langer's lines of skin cleavage, most striking on the back
Collarette of scale — fine, crinkled scale with the open edge toward the center (inward-pointing "hanging curtain sign")
Moderate pruritus — may be intense during outbreak
Mild constitutional prodrome (malaise, pharyngitis) may precede the rash

Classic pityriasis rosea — herald patch on shoulder with secondary Christmas-tree eruption across the anterior trunk (DermNet)

Classic presentation: herald patch on left shoulder with generalized secondary eruption across the trunk (DermNet)

Salmon-colored coalescing plaques with characteristic fine scaling on the trunk (Andrews' Fig. 11.1)

Confluent salmon-pink plaques with fine crinkled scale — trunk (Andrews' Diseases of the Skin, Fig. 11.1)

Herald patch with collarette scale on forearm in skin of color (DermNet)

Herald patch with collarette scale on the arm — note presentation in skin of color where erythema may be muted

Generalized pityriasis rosea eruption across the chest and breast region, with visible herald patch (DermNet)

Secondary eruption with scattered oval papules and plaques on the trunk

Atypical Variants

Variant	Features
Papular	Common in children with darker skin; more facial and scalp involvement
Vesicular	Blistering lesions; rare
Purpuric	Petechiae and ecchymoses along Langer lines — rule out underlying leukemia
Erythema multiforme-like	Target-like lesions
Inverse PR	Lesions localized to axillae, groin, or neck, sparing the trunk
Unilateral/segmental	Rare

Pregnancy warning: Pityriasis rosea in the first 15 weeks of gestation is associated with premature delivery, neonatal hypotonia, and fetal loss. — Andrews' Diseases of the Skin

Course

Self-limiting: typical course 3–8 weeks (range 4–16 weeks)
Spontaneous resolution is the rule
Relapses are uncommon
In darker-skinned patients, lesions often resolve with post-inflammatory hypopigmentation

Histology

Mild acanthosis
Focal parakeratosis
Extravasation of erythrocytes into the epidermis (characteristic)
Spongiosis (especially in acute cases)
Mild perivascular lymphocytic infiltrate in the dermis — Andrews' Diseases of the Skin

Differential Diagnosis

Condition	Key Distinguishing Feature
Secondary syphilis	Involves palms and soles; generalized adenopathy; positive RPR/VDRL — always rule out
Tinea corporis	Rarely so widespread; positive KOH
Tinea versicolor	Flatter, smaller lesions; KOH positive
Guttate psoriasis	No collarette of scale; silvery-white scale
Seborrheic dermatitis	Greasy scales; scalp and eyebrow involvement
Drug eruption	History of offending drug
Lichen planus	Violaceous, pruritic flat-topped papules; Wickham's striae

Syphilis testing (RPR) is advisable in any atypical case — especially with palm/sole involvement or when clinical doubt exists. Syphilis incidence is rising and it can closely mimic PR. — Andrews'; Goldman-Cecil

Treatment

Most patients require no specific therapy as the condition is self-limiting. Treatment aims to reduce pruritus and potentially shorten duration.

1. Symptomatic / First-Line

Treatment	Details
Oral antihistamines	Non-sedating (e.g. cetirizine, loratadine) for pruritus
Topical corticosteroids	Triamcinolone 0.1% cream for pruritic areas
Emollients	Petroleum jelly-based preparations; reduce dryness and itch
Patient reassurance	Self-limiting; no isolation needed

2. Antiviral Therapy

Acyclovir — the most evidence-supported specific treatment. Multiple trials have shown it decreases the eruption and itching when given early (within the first week). Dose commonly used: 800 mg five times daily for 7 days.
In pregnant patients (especially early in pregnancy), acyclovir could be considered given the risk of fetal harm from the eruption, in consultation with an obstetrician. — Andrews' Diseases of the Skin

3. Phototherapy

Narrowband UVB (NB-UVB) phototherapy — from a dermatologist — may speed resolution of lesions
Natural sunlight exposure also reported to help — Tintinalli's Emergency Medicine

4. Antibiotics (Limited Role)

Erythromycin — demonstrated benefit in small studies, but GI side effects limit use
Macrolides generally not indicated per current evidence — Tintinalli's; Andrews'

A Cochrane review has cited inadequate evidence for most published treatments; however, lack of evidence does not equate to lack of efficacy. The best available evidence supports acyclovir as the most effective intervention for reducing duration and pruritus. — Andrews' Diseases of the Skin

Summary Table

Feature	Details
Etiology	HHV-6 / HHV-7 reactivation
Age	15–40 years most common
Season	Spring and autumn
Herald patch	50–90%; precedes generalized rash by 1–2 weeks
Distribution	Trunk, proximal limbs; Christmas-tree pattern along Langer lines
Duration	3–8 weeks (up to 16 weeks)
Key diagnostic sign	Collarette of scale (inward-pointing)
Must-exclude	Secondary syphilis
Treatment	Symptomatic (antihistamines, topical steroids, emollients); acyclovir for severe/early cases; NB-UVB phototherapy
Prognosis	Excellent; self-limiting; recurrence uncommon

Sources: Andrews' Diseases of the Skin (9780323547536); Tintinalli's Emergency Medicine (9781260019933); Goldman-Cecil Medicine (9780323930345); DermNet clinical images

Make a handwritten notes with images

Asking for Preferences

Reading File

Running Command

Writing File

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.